Close Menu

More articles about Microarrays & Multiplexing

An analysis of almost 43,000 individuals under 17 years suggests polygenic scores for adult conditions such as depression may coincide with childhood psychopathology.

Combining questionnaire-derived phenotyping with hospital diagnoses increases the power to tease out genetic associations within biobank data.

Drawing from its massive consumer genetic dataset and longitudinal survey data, 23andMe is searching for genetic features that might influence the severity of SARS-CoV-2 infections.

The investment bank said the company's molecular diagnostics have the potential to replace microarrays for cytogenetics analysis.

The company said its product and services revenues were about $24.5 million for the quarter, 15 percent higher than the same period last year.

Women with breast cancer from Peru, Mexico, or Colombia who had greater Indigenous American ancestry were more likely to have HER2-positive tumors.

Using data for more than half a million individuals, researchers identified 449 refractive area-related loci, including 336 sites not linked to the eye condition in the past.

Investigators worldwide are sharing data to search for features in the human genome that might contribute to COVID-19 susceptibility or progression.

High throughput and deep coverage have allowed firms like Olink and Somalogic to make inroads, especially among researchers working outside proteomics.

The company said the test achieved 100 sensitivity and 100 percent specificity in a study of 210 samples that included 44 from COVID-19 patients.

The partners' "COVID-19 task force" will invest in ePlex molecular testing platforms from GenMark Diagnostics to quadruple UCSF's testing capacity.

The study suggested that ALL glucocorticoid resistance stemming from alterations that drive down CELSR2 levels might be combated with the BCL2-targeting drug venetoclax.

Genomica, a PharmaMar Group company, has developed kits based on real-time PCR and its CLART low-density microarray technology.

Some of the market's most influential voices, including Kári Stefánsson and Linda Avey, believe that consumer genomics is not on the way out but rather experiencing a period of transition.

A genetic analysis based on more than 32,000 individuals living in the US traced the ancestry, historical migration, and other patterns present in populations around the country.

A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions.

The company intends to use most of the proceeds to pay off debts and associated fees, and the rest to support its platform and consumables development. 

The company intends to use most of the proceeds to pay off debts and associated fees, and the rest to support its platform and consumables development.

Boston-based NanoView aims to make its extracellular vesicle detection technology more widely available for research and biomarker discovery.

The firm said current adoption is robust, but enabling readout on NGS instruments this summer will be crucial to opening a much larger customer base.

Pages

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.